Oral Potentially Malignant Disorders · Prevention & risk

What are the risk factors for oral potentially malignant disorders?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Oral Potentially Malignant Disorders Answer length: short, citable
Quick answer

The main recognised risk factors for oral potentially malignant disorders are areca nut / betel quid chewing, with or without tobacco — IARC Group 1 carcinogen, smokeless tobacco (gutka, khaini, zarda, snuff, toombak) and cigarette, bidi or pipe smoking and heavy alcohol use. Risks differ by region: India has a distinctive exposure pattern, so a patient's country of residence is part of the risk assessment. Having a risk factor does not mean a person will develop cancer.

In detail

Risk factors are probabilistic. Many patients have no obvious exposure, and most people with an exposure never develop a head and neck tumour. Tell your clinician about all tobacco, areca nut, alcohol, occupational and viral exposures, because this information changes follow-up planning.

  • Areca nut / betel quid chewing, with or without tobacco — IARC Group 1 carcinogen
  • Smokeless tobacco (gutka, khaini, zarda, snuff, toombak)
  • Cigarette, bidi or pipe smoking and heavy alcohol use
  • Chronic mechanical trauma from sharp teeth, rough restorations or ill-fitting dentures
  • Oral submucous fibrosis, oral lichen planus and prior oral cancer
  • Immunosuppression and, for actinic cheilitis, cumulative UV exposure

What this means in practice: this answer is part of the “Prevention & risk” section of the Oral Potentially Malignant Disorders topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about oral potentially malignant disorders

See all 13 questions in this topic →

Sources for this answer

  1. Smokeless Tobacco and Oral Cancer in Global Perspective New England Journal of Medicine · 2026 · More than 360 million users of smokeless tobacco; ~120,000 oral cancer cases attributable to smokeless tobacco, areca nut or both in 2022.
  2. Oral cancer burden and mortality in India: a GLOBOCAN 2022 analysis with regional comparison ecancermedicalscience · 2026 · 143,759 new oral cancer cases and 79,979 deaths in India in 2022.
  3. IARC Monographs on the Identification of Carcinogenic Hazards to Humans (tobacco, areca nut, UV radiation, EBV, HPV) International Agency for Research on Cancer / WHO · 2024
  4. Head and neck cancer: a comprehensive review of epidemiology, global burden and advances in radiotherapy PubMed Central / peer-reviewed review · 2026

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.